Interdisciplinary approach to the management of patients with perforating dermatosis (clinical case)

Authors

DOI:

https://doi.org/10.14739/2310-1237.2025.2.334422

Keywords:

acquired perforating dermatosi, multimorbidity, histological examination, treatment

Abstract

The aim of this work is to describe a clinical case of acquired perforating dermatosis within the context of an interdisciplinary approach to patient management, taking into account a comprehensive therapeutic and dermatological diagnostic and therapeutic algorithm.

Materials and methods. A personal observation is described of a 70-year-old patient with clinical manifestations of acquired perforating dermatosis and multimorbid somatic pathology, the verification of which was carried out taking into account the results of laboratory and instrumental diagnostic methods. The dermatological diagnosis was established based on the morphological assessment of a skin biopsy.

Results. A clinical case of a patient with skin lesions of the trunk and upper extremities is described. Visual manifestations of dermatosis are represented by a papular rash with a central depression, erosions, hyperkeratotic changes, and pronounced itching, which in general mimic a wide range of nosologies: from lichen planus, prurigo to multiple keratoacanthomas. Given such clinical non-specificity of the pathological process on the skin, only morphological diagnostics can contribute to the final verification of the dermatological diagnosis. In addition, an important aspect was the assessment of the patient’s somatic status, which revealed the presence of multimorbidity, in particular concomitant cardiovascular pathology, chronic kidney disease, cryptogenic liver cirrhosis, and portal hypertension. The general therapeutic direction of this disease is to compensate for the underlying somatic pathology. That is why, given the clinical complexity of the condition, patients in this category require the mandatory involvement of physicians from related specialties. In this case, the patient requires constant therapeutic support, including in the conditions of an inpatient ward. Given the severe general status of the patient, it was decided, in parallel with the treatment of somatic pathology, to have a rather gentle effect on the efflorescence, only with the use of systemic antihistamines and topical therapy with glucocorticosteroids. The positive dynamics within the skin justify the expediency of continuing the planned comprehensive therapeutic tactics.

Conclusions. Morphological examination is the gold standard for verifying pathological processes in the skin. Considering the rather variable nosologies in the context of multimorbidity in one patient, as well as the clear dependence of the course of dermatosis on somatic pathology, a mandatory stage in the management of such patients is the joint interdisciplinary work of specialists of both dermatological and therapeutic profiles.

Author Biographies

V. A. Vizir, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor of the Department of Internal Medicine No. 2

H. I. Makurina, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor, Head of the Department of Derma-tovenerology and Aesthetic Medicine

O. V. Demidenko, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, Associate Professor, Head of the Department of Internal Medicine 2

L. O. Horodokina, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, Assistant of the Department of Dermatovenerology and Aesthetic Medicine

References

Harbaoui S, Litaiem N. Acquired Perforating Dermatosis. [Updated 2023 Feb 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539715/

Roldan-Contreras SE, Mendoza Martínez JR, Marin-Hernandez E, Coronado-Malagón M. Acquired Perforating Dermatosis and Dermatology Life Quality Index in Patients Receiving hemodialysis. Nefrologia (Engl Ed). 2024;44(2):251-5. doi: https://doi.org/10.1016/j.nefroe.2024.03.006

Gao Z, Lu SJ, Shan SJ. Acquired perforating dermatosis: A clinicopathologic study, and the features of dermoscopy and reflective confocal microscopy of 37 cases. Skin Res Technol. 2023;29(7):e13416. doi: https://doi.org/10.1111/srt.13416

Mima Y, Ohtsuka T, Ebato I, Nishie R, Uesugi S, Sumi M, et al. A Case of Acquired Reactive Perforating Dermatosis with Complete Resolution of Eruptions on Upper and Lower Limbs During the Treatment of Diabetes Mellitus and Peripheral Artery Disease. Medicina. 2025;61(1):36. doi: https://doi.org/10.3390/medicina61010036

Garrido PM, Queirós C, Borges-Costa J, Soares-Almeida L, Filipe P. Acquired perforating dermatosis: clinicopathologic study of a 10-year period at a tertiary teaching hospital. Int J Dermatol. 2020;59(4):445-50. doi: https://doi.org/10.1111/ijd.14760

Kawakami T, Akiyama M, Ishida-Yamamoto A, Nakano H, Mitoma C, Yoneda K, et al. Clinical practice guide for the treatment of perforating dermatosis. J Dermatol. 2020;47(12):1374-82. doi: https://doi.org/10.1111/1346-8138.15647

García-Malinis AJ, Del Valle Sánchez E, Sánchez-Salas MP, Del Prado E, Coscojuela C, Gilaberte Y. Acquired perforating dermatosis: clinicopathological study of 31 cases, emphasizing pathogenesis and treatment. J Eur Acad Dermatol Venereol. 2017;31(10):1757-63. doi: https://doi.org/10.1111/jdv.14220

Wang MF, Mei XL, Wang L, Lin-Feng L. Clinical characteristics and prognosis of acquired perforating dermatosis: A case report. Exp Ther Med. 2020;19(6):3634-40. doi: https://doi.org/10.3892/etm.2020.8651

Edek YC, Aypek Y, Öğüt B, Erdem Ö, Adışen E. Acquired Perforating Dermatosis: Clinical and Histopathological Analysis of 95 Patients From One Center. Dermatol Pract Concept. 2024;14(2):e2024100. doi: https://doi.org/10.5826/dpc.1402a100

Liu B, Wu Y, Wu X, Zhong X, Xue R, Zhang Z. Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation. Front Immunol. 2023;14:1240262. doi: https://doi.org/10.3389/fimmu.2023.1240262

Metterle L, Magro CM, Zang JB. Giant variant of acquired perforating dermatosis in a renal dialysis patient. JAAD Case Rep. 2017;3(1):42-4. doi: https://doi.org/10.1016/j.jdcr.2016.10.004

Agrawal A, Singal A, Devanda R, Arora VK. Scabies surrepticius masquerading as perforating dermatosis. Indian J Dermatol Venereol Leprol. 2024:1-4. doi: https://doi.org/10.25259/IJDVL_834_2023

Іmran N. Acquired Perforating Dermatosis as a Paraneoplastic Feature: A Case Report, Literature Review, and Novel Association. Case Rep Nephrol Dial. 2023;13(1):36-44. doi: https://doi.org/10.1159/000530756

Wang S, Min X, Wang X, Cheng L, Qiu L. A case of acquired reactive perforating collagenosis after COVID-19 infection. Postepy Dermatol Alergol. 2024;41(5):536-7. doi: https://doi.org/10.5114/ada.2024.142575

Sciamarrelli N, Siliquini N, Mastorino L, Senetta R, Dapavo P, Ribero S, et al. Exacerbation of acquired perforating dermatosis following SARS-CoV-2 vaccination. J Eur Acad Dermatol Venereol. 2023;37(9):e1091-3. doi: https://doi.org/10.1111/jdv.19137

Mądrzak L, Staniszewska I, Moskwa A, Kalińska-Bienias A. Drugs as a cause of perforating dermatoses – a literature review. Dermatology Review/Przegląd Dermatologiczny. 2024;111(3):209-21. doi: https://doi.org/10.5114/dr.2024.144652

Fisher RM, Hadley G, Ieremia E, Moswela O, Zaki F, DeLuca GC, et al. Natalizumab-induced acquired perforating dermatosis. Clin Exp Dermatol. 2021;46(7):1373-5. doi: https://doi.org/10.1111/ced.14699

Liu X, Wang H, Wan Y, Guo Y, Shan SJ. Acquired Perforating Dermatosis Induced by PD-1 Inhibitor: A Case Report. Am J Dermatopathol. 2021;43(12):942-4. doi: https://doi.org/10.1097/DAD.0000000000002026

Du XH, Huang SY, Zeng XF, Lu SJ, Gao Z. Acquired Perforating Dermatosis After Herpes Zoster: Wolf Isotopic Response. J Cutan Pathol. 2025;52(1):16-9. doi: https://doi.org/10.1111/cup.14728

Tai A, Prakash S, Lade S, McCormack CJ, Goh MS. Two cases of acquired perforating dermatosis successfully treated with allopurinol. Australas J Dermatol. 2022;63(1):121-4. doi: https://doi.org/10.1111/ajd.13712

Schremser V, Tittes J, Tanew A, Radakovic S. Sustained clearance of acquired perforating dermatosis after narrowband UVB phototherapy: A retrospective cohort study on seven patients. J Eur Acad Dermatol Venereol. 2023;37(6):e747-8. doi: https://doi.org/10.1111/jdv.18904

Kharghoria G, Grover C. Treatment of acquired perforating dermatosis with colchicine. Indian Dermatol Online J. 2022;13(1):131-2. doi: https://doi.org/10.4103/idoj.IDOJ_163_21

Gil F, Cardoso JC, Gil J. Successful Treatment of Acquired Perforating Dermatosis with Colchicine. Indian Dermatol Online J. 2021;12(2):355-6. doi: https://doi.org/10.4103/idoj.IDOJ_504_20

Ye B, Cao Y, Liu Y. Successful treatment of acquired reactive perforating collagenosis with itraconazole. Eur J Med Res. 2021;26(1):74. doi: https://doi.org/10.1186/s40001-021-00542-6

Gori N, De Luca E, Chiricozzi A, Sfregola S, Di Stefani A, Peris K. Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic Dermatitis. Case Rep Dermatol Med. 2024;2024:6265608. doi: https://doi.org/10.1155/2024/6265608

Alsebayel MM, Alzaid T, Alobaida SA. Dupilumab in acquired perforating dermatosis: A potential new treatment. JAAD Case Rep. 2022;28:34-36. doi: https://doi.org/10.1016/j.jdcr.2022.08.013

Downloads

Additional Files

Published

2025-08-30

How to Cite

1.
Vizir VA, Makurina HI, Demidenko OV, Horodokina LO. Interdisciplinary approach to the management of patients with perforating dermatosis (clinical case). Pathologia [Internet]. 2025Aug.30 [cited 2025Oct.2];22(2):168-74. Available from: https://pat.zsmu.edu.ua/article/view/334422

Issue

Section

Case Reports